Trial Condition(s):

Contraception, Ovulation inhibition, Contraceptives, Oral

Study to evaluate the ovulation inhibitory effect of Minisiston® (0.03 mg Ethinylestradiol and 0.125 mg Levonorgestrel)

Bayer Identifier:

91288

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
32
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Minisiston/Monostep (EE30/LNG, BAY86-4977)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

Trial Design